<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:55:10 -0700</creation_date>
  <update_date>2013-01-15 18:55:10 -0700</update_date>
  <accession>HMDBP01298</accession>
  <secondary_accessions>
    <accession>6594</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>Ceramide transfer protein</synonym>
    <synonym>GPBP</synonym>
    <synonym>Goodpasture antigen-binding protein</synonym>
    <synonym>START domain-containing protein 11</synonym>
    <synonym>StAR-related lipid transfer protein 11</synonym>
    <synonym>StARD11</synonym>
    <synonym>hCERT</synonym>
  </synonyms>
  <gene_name>COL4A3BP</gene_name>
  <general_function>Involved in protein binding</general_function>
  <specific_function>May mediate the intracellular trafficking of ceramide in a non-vesicular manner</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB04947</accession>
      <name>Ceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04952</accession>
      <name>Ceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04957</accession>
      <name>Ceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04956</accession>
      <name>Ceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04951</accession>
      <name>Ceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04954</accession>
      <name>Cer(d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04950</accession>
      <name>Ceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04953</accession>
      <name>Cer(d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04955</accession>
      <name>Cer(d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04948</accession>
      <name>Ceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04949</accession>
      <name>Ceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00790</accession>
      <name>N-Palmitoylsphingosine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00829</accession>
      <name>N-Stearoylsphingosine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00831</accession>
      <name>N-Lignoceroylsphingosine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00950</accession>
      <name>Cer(d18:1/23:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06752</accession>
      <name>Dihydroceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10697</accession>
      <name>Cer(t18:0/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11758</accession>
      <name>Cer(d18:0/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11759</accession>
      <name>Cer(d18:0/14:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11760</accession>
      <name>Cer(d18:0/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11761</accession>
      <name>Cer(d18:0/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11762</accession>
      <name>Cer(d18:0/18:1(11Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11763</accession>
      <name>Cer(d18:0/18:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11764</accession>
      <name>Cer(d18:0/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11765</accession>
      <name>Cer(d18:0/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11766</accession>
      <name>Cer(d18:0/22:1(13Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11767</accession>
      <name>Cer(d18:0/23:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11768</accession>
      <name>Cer(d18:0/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11769</accession>
      <name>Cer(d18:0/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11770</accession>
      <name>Cer(d18:0/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11771</accession>
      <name>Cer(d18:0/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11772</accession>
      <name>Cer(d18:0/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11773</accession>
      <name>Cer(d18:1/14:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11774</accession>
      <name>Cer(d18:1/18:1(11Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11775</accession>
      <name>Cer(d18:1/22:1(13Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00024</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00140</accession>
      <name>Glucosylceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04832</accession>
      <name>Galabiosylceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04833</accession>
      <name>Galabiosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04834</accession>
      <name>Galabiosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04835</accession>
      <name>Galabiosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04836</accession>
      <name>Galabiosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04837</accession>
      <name>Galabiosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04838</accession>
      <name>Galabiosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04839</accession>
      <name>Galabiosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04840</accession>
      <name>Galabiosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04841</accession>
      <name>Galabiosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04866</accession>
      <name>Lactosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04872</accession>
      <name>Lactosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04873</accession>
      <name>Lactosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04874</accession>
      <name>Lactosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04876</accession>
      <name>Lactosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04877</accession>
      <name>Trihexosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04878</accession>
      <name>Trihexosylceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04879</accession>
      <name>Trihexosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04880</accession>
      <name>Trihexosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04881</accession>
      <name>Trihexosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04882</accession>
      <name>Trihexosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04883</accession>
      <name>Trihexosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04884</accession>
      <name>Trihexosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04886</accession>
      <name>Trihexosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04887</accession>
      <name>Trihexosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04958</accession>
      <name>Tetrahexosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04959</accession>
      <name>Tetrahexosylceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04960</accession>
      <name>Tetrahexosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04961</accession>
      <name>Tetrahexosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04962</accession>
      <name>Tetrahexosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04963</accession>
      <name>Tetrahexosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04964</accession>
      <name>Tetrahexosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04965</accession>
      <name>Tetrahexosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04966</accession>
      <name>Tetrahexosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04967</accession>
      <name>Tetrahexosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04968</accession>
      <name>Tetrahexosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04969</accession>
      <name>Glucosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04970</accession>
      <name>Glucosylceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04971</accession>
      <name>Glucosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04972</accession>
      <name>Glucosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04973</accession>
      <name>Glucosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04974</accession>
      <name>Glucosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04975</accession>
      <name>Glucosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04976</accession>
      <name>Glucosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04977</accession>
      <name>Glucosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04978</accession>
      <name>Glucosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04979</accession>
      <name>Glucosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06750</accession>
      <name>Lactosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10708</accession>
      <name>Galactosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10709</accession>
      <name>Galactosylceramide (d18:1/18:0) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB10710</accession>
      <name>Galactosylceramide (d18:1/20:0) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB10711</accession>
      <name>Galactosylceramide (d18:1/22:0) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB10712</accession>
      <name>Galactosylceramide (d18:1/24:1(15Z)) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB10713</accession>
      <name>Galactosylceramide (d18:1/26:1(17Z)) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB10714</accession>
      <name>Galactosylceramide (d18:1/18:1(9Z)) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB11591</accession>
      <name>Lactosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11592</accession>
      <name>Lactosyceramide (d18:1/18:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11594</accession>
      <name>Lactosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11595</accession>
      <name>Lactosylceramide (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12237</accession>
      <name>Inositol-P-ceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12256</accession>
      <name>Mannosyl-diinositol-phosphorylceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12257</accession>
      <name>Mannosyl-inositol-phosphorylceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12311</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12312</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/14:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12313</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12314</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12315</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12316</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12317</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/18:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12318</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12319</accession>
      <name>3-O-Sulfogalactosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12320</accession>
      <name>Galactosylceramide (d18:1/12:0) </name>
    </metabolite>
    <metabolite>
      <accession>HMDB12321</accession>
      <name>Galactosylceramide (d18:1/14:0) </name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Cytoplasm</subcellular_location>
    <subcellular_location>Golgi apparatus</subcellular_location>
    <subcellular_location>Endoplasmic reticulum</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:5</chromosome_location>
    <locus>5q13.3</locus>
    <gene_sequence>&gt;1875 bp
ATGTCGGATAATCAGAGCTGGAACTCGTCGGGCTCGGAGGAGGATCCAGAGACGGAGTCT
GGGCCGCCTGTGGAGCGCTGCGGGGTCCTCAGTAAGTGGACAAACTACATTCATGGGTGG
CAGGATCGTTGGGTAGTTTTGAAAAATAATGCTCTGAGTTACTACAAATCTGAAGATGAA
ACAGAGTATGGCTGCAGAGGATCCATCTGTCTTAGCAAGGCTGTCATCACACCTCACGAT
TTTGATGAATGTCGATTTGATATTAGTGTAAATGATAGTGTTTGGTATCTTCGTGCTCAG
GATCCAGATCATAGACAGCAATGGATAGATGCCATTGAACAGCACAAGACTGAATCTGGA
TATGGATCTGAATCCAGCTTGCGTCGACATGGCTCAATGGTGTCCCTGGTGTCTGGAGCA
AGTGGCTACTCTGCAACATCCACCTCTTCATTCAAGAAAGGCCACAGTTTACGTGAGAAG
TTGGCTGAAATGGAAACATTTAGAGACATCTTATGTAGACAAGTTGACACGCTACAGAAG
TACTTTGATGCCTGTGCTGATGCTGTCTCTAAGGATGAACTTCAAAGGGATAAAGTGGTA
GAAGATGATGAAGATGACTTTCCTACAACGCGTTCTGATGGTGACTTCTTGCATAGTACC
AACGGCAATAAAGAAAAGTTATTTCCACATGTGACACCAAAAGGAATTAATGGTATAGAC
TTTAAAGGGGAAGCGATAACTTTTAAAGCAACTACTGCTGGAATCCTTGCAACACTTTCT
CATTGTATTGAACTAATGGTTAAACGTGAGGACAGCTGGCAGAAGAGACTGGATAAGGAA
ACTGAGAAGAAAAGAAGAACAGAGGAAGCATATAAAAATGCAATGACAGAACTTAAGAAA
AAATCCCACTTTGGAGGACCAGATTATGAAGAAGGCCCTAACAGTCTGATTAATGAAGAA
GAGTTCTTTGATGCTGTTGAAGCTGCTCTTGACAGACAAGATAAAATAGAAGAACAGTCA
CAGAGTGAAAAGGTGAGATTACATTGGCCTACATCCTTGCCCTCTGGAGATGCCTTTTCT
TCTGTGGGGACACATAGATTTGTCCAAAAGCCCTATAGTCGCTCTTCCTCCATGTCTTCC
ATTGATCTAGTCAGTGCCTCTGATGATGTTCACAGATTCAGCTCCCAGGTTGAAGAGATG
GTGCAGAACCACATGACTTACTCATTACAGGATGTAGGCGGAGATGCCAATTGGCAGTTG
GTTGTAGAAGAAGGAGAAATGAAGGTATACAGAAGAGAAGTAGAAGAAAATGGGATTGTT
CTGGATCCTTTAAAAGCTACCCATGCAGTTAAAGGCGTCACAGGACATGAAGTCTGCAAT
TATTTCTGGAATGTTGACGTTCGCAATGACTGGGAAACAACTATAGAAAACTTTCATGTG
GTGGAAACATTAGCTGATAATGCAATCATCATTTATCAAACACACAAGAGGGTGTGGCCT
GCTTCTCAGCGAGACGTATTATATCTTTCTGTCATTCGAAAGATACCAGCCTTGACTGAA
AATGACCCTGAAACTTGGATAGTTTGTAATTTTTCTGTGGATCATGACAGTGCTCCTCTA
AACAACCGATGTGTCCGTGCCAAAATAAATGTTGCTATGATTTGTCAAACCTTGGTAAGC
CCACCAGAGGGAAACCAGGAAATTAGCAGGGACAACATTCTATGCAAGATTACATATGTA
GCTAATGTGAACCCTGGAGGATGGGCACCAGCCTCAGTGTTAAGGGCAGTGGCAAAGCGA
GAGTATCCTAAATTTCTAAAACGTTTTACTTCTTACGTCCAAGAAAAAACTGCAGGAAAG
CCTATTTTGTTCTAG</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>624</residue_number>
    <molecular_weight>70834.4</molecular_weight>
    <theoretical_pi>5.15</theoretical_pi>
    <pfams>
      <pfam>
        <name>PH</name>
        <pfam_id>PF00169</pfam_id>
      </pfam>
      <pfam>
        <name>START</name>
        <pfam_id>PF01852</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
      <region>None</region>
    </transmembrane_regions>
    <signal_regions>
      <region>None</region>
    </signal_regions>
    <protein_sequence>&gt;Collagen type IV alpha-3-binding protein
MSDNQSWNSSGSEEDPETESGPPVERCGVLSKWTNYIHGWQDRWVVLKNNALSYYKSEDE
TEYGCRGSICLSKAVITPHDFDECRFDISVNDSVWYLRAQDPDHRQQWIDAIEQHKTESG
YGSESSLRRHGSMVSLVSGASGYSATSTSSFKKGHSLREKLAEMETFRDILCRQVDTLQK
YFDACADAVSKDELQRDKVVEDDEDDFPTTRSDGDFLHSTNGNKEKLFPHVTPKGINGID
FKGEAITFKATTAGILATLSHCIELMVKREDSWQKRLDKETEKKRRTEEAYKNAMTELKK
KSHFGGPDYEEGPNSLINEEEFFDAVEAALDRQDKIEEQSQSEKVRLHWPTSLPSGDAFS
SVGTHRFVQKPYSRSSSMSSIDLVSASDDVHRFSSQVEEMVQNHMTYSLQDVGGDANWQL
VVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHV
VETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPL
NNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKR
EYPKFLKRFTSYVQEKTAGKPILF</protein_sequence>
  </protein_properties>
  <genbank_protein_id>5031717</genbank_protein_id>
  <uniprot_id>Q9Y5P4</uniprot_id>
  <uniprot_name>C43BP_HUMAN</uniprot_name>
  <pdb_ids>
  </pdb_ids>
  <genbank_gene_id>NM_005713.2</genbank_gene_id>
  <genecard_id>COL4A3BP</genecard_id>
  <geneatlas_id>COL4A3BP</geneatlas_id>
  <hgnc_id>HGNC:2205</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Raya A, Revert F, Navarro S, Saus J: Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen. J Biol Chem. 1999 Apr 30;274(18):12642-9.</reference_text>
      <pubmed_id>10212244</pubmed_id>
    </reference>
    <reference>
      <reference_text>Raya A, Revert-Ros F, Martinez-Martinez P, Navarro S, Rosello E, Vieites B, Granero F, Forteza J, Saus J: Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J Biol Chem. 2000 Dec 22;275(51):40392-9.</reference_text>
      <pubmed_id>11007769</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M: Molecular machinery for non-vesicular trafficking of ceramide.  Nature. 2003 Dec 18;426(6968):803-9.</reference_text>
      <pubmed_id>14685229</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.</reference_text>
      <pubmed_id>17081983</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kawano M, Kumagai K, Nishijima M, Hanada K: Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem. 2006 Oct 6;281(40):30279-88. Epub 2006 Aug 8.</reference_text>
      <pubmed_id>16895911</pubmed_id>
    </reference>
    <reference>
      <reference_text>Fugmann T, Hausser A, Schoffler P, Schmid S, Pfizenmaier K, Olayioye MA: Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein. J Cell Biol. 2007 Jul 2;178(1):15-22. Epub 2007 Jun 25.</reference_text>
      <pubmed_id>17591919</pubmed_id>
    </reference>
    <reference>
      <reference_text>Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation.  Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. Epub 2008 Jul 31.</reference_text>
      <pubmed_id>18669648</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.</reference_text>
      <pubmed_id>19690332</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
